The Mutual Recognition Procedure (MRP) allows a medicine already authorised in one EU Member State to have its MA recognised in other European countries.
The application relies on the evaluation by the Reference Member State (RMS), which must be accepted by the other states.
This procedure facilitates harmonised market access across the EU without requiring the centralised procedure.
